Neuren Pharmaceuticals | NEU - 销售和管理费用

股票价格
12.58
每天变化
-0.42 -3.23%
每月一次
-1.33%
每年
31.45%
Q2 预测
11.77




销售和管理费用 更改 日
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 585K 84K 2025-09
Avita Medical AUD 19.03M 1.95M 2025-12
Clinuvel Pharmaceuticals AUD 3.85M 5.27M 2025-12
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Genetic Signatures AUD 908K 31K 2025-12
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organon & Co USD 399M 54M 2025-09
Paradigm Biopharmaceuticals AUD 2.83M 1.22M 2025-12
PYC Therapeutics AUD 328.4K 1.8M 2025-12
Starpharma Holdings AUD 4.42M 2.86M 2025-12
Tectonic Therapeutic USD 3.44M 1.52M 2025-12
Telix Pharmaceuticals AUD 93.48M 1.04M 2025-12
Viatris USD 1.03B 144.1M 2025-12
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12